Mental Health Benefits: A Must-Have Resource for Employees
“Mental health benefits are just as important as physical health benefits,” says Dr. Sherry Benton, founder of digital behavioral health platform TAO Connect, a UF startup and UF Innovate | Accelerate at The Hub graduate.
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines
Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announced positive preclinical data supporting the activity of SBP-101 in ovarian cancer cell lines.
SATLANTIS, the Company That Manufactures Small Satellites for NASA
SATLANTIS specializes in making small cameras and satellites, weighing around 50 kilos, something that is not widely used on the market. Most companies are dedicated to making large satellites and this is where Juan Tomás Hernani, SATLANTIS' CEO, believes that one of the keys to his success is.
Digital Behavioral Health Platform TAO Connect Launches New Learner Dashboard, Offering Users Greater Personalization Experience
UF startup and UF Innovate | Accelerate at The Hub graduate TAO Connect, a digital platform designed to make behavioral health care more accessible and effective, announced the launch of its brand new Learner Dashboard.
Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., in collaboration with researchers from Florida International University’s Department of Physics and Biomolecular Sciences Institute, announced the publication of a study entitled “Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides.”
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
UF startup and Sid Martin Biotech alumni company Oragenics, Inc. announced the results from its study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study. The study provided preclinical data for formulations designed for both intranasal and intramuscular administration.
CDTI Enters in SATLANTIS’ Capital, in a 16.5 Million Round of Investment
With the entry of CDTI (the Centre for the Development of Industrial Technology) in its capital, UF startup and UF Innovate | Accelerate at The Hub resident SATLANTIS has closed its second-round investment to which Enagás, Sepi, Orza and Axis-Ico are also incorporated, for a cumulative total of 16.5 million euros.
DNAtrix Announces Oral Presentation of Positive Overall Survival Data With DNX-2401 in DIPG at the Society for Neuro-Oncology (SNO) Annual Meeting
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced that data from the Phase 1 study of DNX-2401 in diffuse intrinsic pontine glioma (DIPG) was presented in an oral presentation at the 26th Annual Meeting and Education Day of the Society for Neuro-oncology (SNO), which was held from November 18-21, 2021 in Boston, MA.
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to Its Board of Directors
UF startup and UF Innovate | Accelerate at Sid Martin Biotech graduate Lacerta Therapeutics, Inc., a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
Talking About Feeling: Axogen Raises Awareness for Mastectomy Side Effect
In the wake of Breast Cancer Awareness Month, UF startup and UF Innovate | Accelerate at Sid Martin Biotech graduate Axogen has expanded the scope of a campaign to raise awareness about a side effect of mastectomies.
